Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • Pfizer Inc. News

    23,89 € +0,17% +0,04 €
    11:34:11 Uhr Tradegate aktualisieren | Orderbuch | Mehr Kurse »
    WKN: 852009
    ISIN: US7170811035
    US-Symbol: PFE
    Typ: Aktie
    Werbung

    Attraktive Knock-Outs auf Pfizer Inc.

    Typ Hebel Bid / Ask WKN Typ Hebel Bid / Ask WKN
    Call
    		4,9 0,48 € / 0,49 €
    SU32LG
    Put
    		4,8 4,95 € / 5,04 €
    SU7U9R
    Call
    		10,2 0,23 € / 0,24 €
    SW3YJN
    Put
    		9,0 2,62 € / 2,71 €
    SW5HS2
    Den Basisprospekt sowie endgültige Bedingungen und Basisinformationsblätter erhalten Sie bei Klick auf das Dokument-Icon. Beachten Sie auch die weiteren Hinweise zu dieser Werbung. Der Emittent ist berechtigt, Wertpapiere mit open end-Laufzeit zu kündigen.
    Alle Knock-Outs auf Pfizer Inc.
    Werbung
    Weiter aufwärts?
    Long Hebel 10,10
    MB6R47

    Unternehmensmeldungen

    11.04.24 - Businesswire
    Pfizer Invites Shareholders to Attend Virtual-Only 2024 Annual Meeting of Shareholders on April 25
    Pfizer Inc. (NYSE: PFE) announced today that its shareholders and the general public are invited to access its virtual-​only 2024 Annual Meeting of Shareholders at 9:00 a.m. EDT on ...
    09.04.24 - Businesswire
    Pfizer Announces Positive Top-Line Results from Phase 3 Study of ABRYSVO® in Adults Aged 18 to 59 at Increased Risk for RSV Disease
    Pfizer Inc. (NYSE: PFE) today announced positive top-line immunogenicity and safety data from the ongoing pivotal Phase 3 clinical trial ( NCT05842967 ) MONeT (RSV I M munizati ...
    20.03.24 - Businesswire
    Pfizer Invites Public to View and Listen to Webcast of May 1 Conference Call with Analysts
    Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EDT on Wednesday, May 1, ...
    05.03.24 - Businesswire
    Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
    Pfizer Inc. (NYSE: PFE) invites investors and the general public listen to a webcast of a discussion with Mikael Dolsten, Chief Scientific Officer & President, Pfizer Research and ...
    29.02.24 - Businesswire
    Pfizer Oncology Hosts Innovation Day, Highlighting Fully Integrated Organization, Robust Portfolio, and Strategic Priorities to Drive Long-Term Sustainable Growth
    At a meeting with the investment community today, Pfizer Inc. (NYSE: PFE) outlined its strategic priorities for the newly formed Oncology organization — and how its deep and diverse ...
    29.02.24 - Businesswire
    Pfizer Announces Positive Top-Line Data for Full Season Two Efficacy of ABRYSVO® for RSV in Older Adults
    Pfizer Inc. (NYSE: PFE) today announced top-line ABRYSVO ® vaccine efficacy and safety data for respiratory syncytial virus (RSV) in adults 60 years of age and older following a ...
    26.02.24 - Businesswire
    Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
    Pfizer Inc. (NYSE: PFE) invites investors and the general public to listen to a webcast of a discussion with David Denton, Chief Financial Officer, Executive Vice President, at the TD ...
    15.02.24 - Businesswire
    Pfizer Invites Public to Register for Webcast of Pfizer Oncology Innovation Day
    Pfizer Inc. (NYSE: PFE) invites investors and the general public to access a live video webcast of its Oncology Innovation Day on Thursday, February 29, 2024, from 1:00 p.m. EST to ...
    05.02.24 - Businesswire
    Breaking Barriers in Cancer Care: The American Cancer Society and Pfizer Announce a $15 Million, Three-Year Initiative to Bridge the Gap in Cancer Care Disparities
    The American Cancer Society (ACS) and Pfizer Inc. (NYE: PFE) today announced the launch of “Change the Odds™: Uniting to Improve Cancer Outcomes,” a three-​year initiative to ...
    07.06.22 - DGAP
    Hardman & Co Life Sciences Research: Long-term cost and EBIT analysis of the pharmaceutical industry
    Hardman & Co Research Hardman & Co Life Sciences Research: Long-term cost and EBIT analysis of the pharmaceutical industry 07-Jun-2022 / 07:30 GMT/BST Hardman & Co ...
    17.02.21 - DGAP
    Imcyse Raises Additional EUR 21.3 Million in Series B Financing Round - Pfizer Joins as Newest Shareholder
    DGAP-News: Imcyse SA / Key word(s): Financing Imcyse Raises Additional EUR 21.3 Million in Series B Financing Round - Pfizer Joins as Newest Shareholder 17.02.2021 / 14:00 ...
    03.02.21 - DGAP
    Imcyse scelle avec Pfizer un accord de collaboration de recherche et de licence portant sur sa technologie Imotope(TM) dans le domaine de la polyarthrite rhumatoïde
    Imcyse SA / Mot-clé(s) : Autres Imcyse scelle avec Pfizer un accord de collaboration de recherche et de licence portant sur sa technologie Imotope(TM) dans le domaine de la ...
    03.02.21 - DGAP
    Imcyse Enters into Research Collaboration and License Agreement for its ImotopeTM Technology with Pfizer in Rheumatoid Arthritis
    DGAP-News: Imcyse SA / Key word(s): Agreement Imcyse Enters into Research Collaboration and License Agreement for its ImotopeTM Technology with Pfizer in Rheumatoid ...
    24.09.20 - DGAP
    Medizintechnikunternehmen avateramedical N.V. beruft Ian Read, ehemaliger Chairman und CEO von Pfizer, in den Aufsichtsrat
    DGAP-News: avateramedical GmbH / Schlagwort(e): Personalie Medizintechnikunternehmen avateramedical N.V. beruft Ian Read, ehemaliger Chairman und CEO von Pfizer, in den ...
    05.08.19 - DGAP
    Form 8.3 - The Vanguard Group, Inc.: BCA Marketplace plc
    The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: BCA Marketplace plc 05-Aug-2019 / 14:20 GMT/BST Dissemination of a Regulatory Announcement, transmitted by ...
    02.05.19 - DGAP
    Empower Clinics Inc.: Nach Mega-Übernahme - Größter Cannabis Klinikbetreiber der USA entsteht! Kursanstieg voraus!
    DGAP-​Media / 02.05.2019 / 08:42
    09.04.19 - DGAP
    Hardman & Co Research: Global Pharmaceuticals: 2018 industry sales
    Hardman & Co Research Hardman & Co Research: Global Pharmaceuticals: 2018 industry sales 09-Apr-2019 / 16:10 GMT/BST
    02.04.19 - DGAP
    Empower Clinics Inc.: Überraschender Einstieg von Agraflora bei Empower - deutliche Kursteigerung bei Empower heute möglich!
    DGAP-​Media / 02.04.2019 / 11:45
    12.03.19 - DGAP
    Empower Clinics Inc.: Die Turnaround-Story der Cannabis Branche! Eigene CBD Produkte und Neues Management generieren Millioneneinnahmen!
    DGAP-​Media / 12.03.2019 / 08:00
    06.02.19 - DGAP
    Resinco Capital Partners Inc.: Verstärkung des Managements durch weltweit führenden Immunologen - Resinco bestens für den Cannabis Markt 2.0 gerüstet
    DGAP-​Media / 06.02.2019 / 07:37

    Newssuche

    Videos

    newspaper
    18.04.24
    Technical Trading: Gold mit weiterem Potenzial
    Gold Long Typ: Turbo Open End WKN: UH4MU6 Hebel: 4,67 Laufzeit: OpenEnd Einstieg: Market ... Mehr »